New Hampshire-based Vapotherm – a maker of advanced respiratory care devices – just raised what looks like a $20 million Series C round, according to a regulatory filing.
The company builds breathing tubes for patients with respiratory issues – from neonatal to geriatric. They’re meant for patients with conditions like asthma, COPD, bronochiolitis and congestive heart failure. It holds a robust international patent portfolio for hospital and home care breathing tubes – heating and humidifying breathing gases.
Last year, Vapotherm closed out a $24 million Series B, led by Gilde Healthcare Partners, but with new investor Adage Capital Management and existing investors 3×5
9 Ways to Find Caregivers With Flexible Scheduling Options
Discover nine top caregiver services with flexible scheduling to fit changing routines, shift work or evolving health needs — featuring trusted platforms and in-home care providers.
Calls to Vapotherm about this new funding round have yet to be returned.